San Diego, CA \u2013 June 3, 2015 \u2013 The entrepreneurial spirit is thriving in New York. As the state prepares for medical cannabis availability, cultivation and dispensary licenses are popular topics of conversation. The International Cannabis Association is assisting enterprising individuals and companies with plans to join the industry by hosting the Cannabis World Congress & Business Expo held in New York City June 17-19.<\/p>\n
There, Medical Marijuana, Inc.\u2019s (OTC Pink: MJNA) portfolio company, HempMeds\u2122, will exhibit a wide range of industrial hemp oil retail products including the groundbreaking product Real Scientific Hemp Oil\u2122 (RSHO\u2122) that is helping to reshape international cannabis law in Brazil. \u201cIt will take more than a year for New York\u2019s medical cannabis law to take effect,\u201d states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. \u201cHempMeds is participating in the Cannabis World Congress & Business Expo to showcase hemp-based cannabis products that are available for resale today. These innovative products represent an immediately viable entry point into the market for entrepreneurs who are considering retail locations.\u201d<\/p>\n
MJNA\u2019s investments and portfolio companies\u2019 hemp oil retail brands planned for display in HempMeds\u2019 exhibit at the Cannabis World Congress & Business Expo include:<\/p>\n
\u201cMJNA\u2019s investment and portfolio company brands are changing hearts and minds around the world,\u201d continues Dr. Titus. \u201cWe are seeing growing acceptance of hemp products in the U.S. – and internationally; in Brazil an epic change in the country\u2019s cannabis law permits RSHO\u2122 for import, through HempMeds Brasil\u2122 and accompanied by required documentation.\u201d<\/p>\n
Dr. Titus concludes, \u201cAs the USA\u2019s first publicly traded cannabis company, MJNA invests in and fosters the growth of industrial hemp and cannabis industry innovations. We would like to thank the International Cannabis Association for the opportunity to educate prospective entrepreneurs attending the New York City Cannabis World Congress & Business Expo about hemp history and industrial hemp. Our representatives look forward to discussing the vast possibilities that the cannabis industry provides.\u201d<\/p>\n
Guest speakers at the Cannabis World Congress & Business Expo include Medical Marijuana, Inc.\u2019s portfolio investment company, KannaLife Sciences (\u201cKannaLife\u201d), which was recently featured in CNN\u2019s Weed 3: The Marijuana Revolution. KannaLife\u2019s work to develop a solution for Chronic Traumatic Encephalopathy (CTE) is critical; it gives hope to not only professional athletes but those in collegiate and youth sports to members of the armed forces and those affected by a traumatic brain injury. Mr. Dean Petkanas, CEO of KannaLife stated in Weed 3 \u2013 The Marijuana Revolution, \u201cHopefully we can intervene in the process of late-stage neurodegeneration and suspend the process.\u201d For more information on KannaLife, visit the Company\u2019s website.<\/p>\n
The Cannabis World Congress & Business Expo takes place at the Javits Center in New York City June 17-19. There is a cost for entry into the conference that is open to the public; details are found on the conference website.<\/p>\n
For more information on HempMeds\u2122 and their all-natural CBD hemp oil products, visit:\u00a0www.hempmeds.com<\/a>. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds\u2122 through the Company\u2019s social media websites on Facebook and Twitter.<\/p>\n About HempMeds Brasil and LLC HempMeds PX, LLC<\/p>\n HempMeds\u00ae\u00a0is a corporate affiliated company of\u00a0Medical Marijuana, Inc.\u00a0(OTC Pink: MJNA) and is its\u00a0exclusive\u00a0distributor of RSHO\u2122. HempMeds Brasil\u2122\u00a0offers specialized marketing, sales, customer\u00a0service, and logistics to supply natural hemp oil rich in CBD to the medical community and families of\u00a0Brazil.<\/p>\n For more information on HempMeds Brasil\u2122 and their all-natural hemp oil products, visit:\u00a0http:\/\/www.hempmeds.com.br<\/a>. The Company invites the public to get involved in the conversation on\u00a0the expanding cannabis industry with HempMeds Brasil\u2122 through the Company\u2019s social media\u00a0channels Facebook<\/a>, Twitter<\/a> and blog.<\/p>\n About KannaLife Sciences, Inc.<\/p>\n KannaLife Sciences, Inc. is a bio-pharmaceutical and phyto-medical company involved in the\u00a0research and development of novel therapeutic agents designed to be neuroprotectants and immuno-modulators. KannaLife is currently conducting research and development at the Pennsylvania\u00a0Biotechnology Center in Doylestown, PA, for target drug candidates to treat Hepatic Encephalopathy\u00a0(\u201cHE\u201d) and Chronic Traumatic Encephalopathy (\u201cCTE\u201d). HE and CTE are oxidative stress related\u00a0diseases that affect cognitive and behavioral functions. For more information, visit KannaLife.com<\/a>.<\/p>\n About Medical Marijuana Inc.<\/p>\n Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of\u00a0professionals to source, evaluate and purchase value-added companies and products, while allowing\u00a0them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our\u00a0industry, develop environmentally-friendly, economically sustainable businesses, while increasing\u00a0shareholder value. For more information, please visit the company’s website at:\u00a0www.MedicalMarijuanaInc.com<\/a>.<\/p>\n FORWARD-LOOKING DISCLAIMER<\/p>\n This press release may contain certain forward-looking statements and information, as defined within\u00a0the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange\u00a0Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains\u00a0statements about expected future events and\/or financial results that are forward-looking in nature\u00a0and subject to risks and uncertainties. Such forward-looking statements by definition involve risks,\u00a0uncertainties and other factors, which may cause the actual results, performance or achievements of\u00a0Medical Marijuana, Inc. to be materially different from the statements made herein.<\/p>\n LEGAL DISCLOSURE<\/p>\n Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of\u00a0the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and\u00a0distribute hemp-based products and are involved with the federally legal distribution of medical\u00a0marijuana-based products within certain international markets. Cannabidiol is a natural constituent of\u00a0hemp oil.<\/p>\n For further information, please contact:<\/p>\n Public Relations contact:<\/p>\n Andrew Hard Corporate contact: Investor Relations: Nick Massalas \u201cLow THC Cannabis\u201d Retail Products Showcased in New York by Hemp Industry Innovator San Diego, CA \u2013 June 3, 2015 \u2013 The entrepreneurial spirit is thriving in New York. As the state prepares for medical cannabis availability, cultivation and dispensary licenses are popular topics of conversation. The International Cannabis Association is assisting enterprising individuals and […]<\/p>\n","protected":false},"author":1,"featured_media":3354,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[3,22,216,163,2],"tags":[167,266,179],"class_list":["post-3353","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","category-hempmeds","category-kannakick","category-kannalife-sciences","category-press-releases","tag-hempmeds","tag-kannakick","tag-kannalife-sciences"],"yoast_head":"\n
\nSpokesperson
\nCMW Media
\nP. 858-380-5478
\nandrew.hard@cmwmedia.com<\/p>\n
\nMedical Marijuana, Inc.
\nToll Free: 888-OTC-MJNA (888-682-6562)
\nwww.medicalmarijuanainc.com<\/a>
\nwww.facebook.com\/mjnainc<\/a><\/p>\n
\nGH Investment Advisors
\n550 West “C” Street, Ste. 2040
\nSan Diego, CA 92101<\/p>\n
\nOffice:\u00a0\u00a0(858) 264-6500
\nToll Free:\u00a0(877) 964-6463
\ninfo@ghinvestmentadvisors.com \t<\/p>\n","protected":false},"excerpt":{"rendered":"